Author | Clarke A. Low, MD | OncLive

Author | Clarke A. Low, MD

Articles

Dr. Low on Osimertinib Versus Dacomitinib in EGFR-Mutant NSCLC

October 30, 2019

Video

Clarke A. Low, MD, discusses osimertinib (Tagrisso) versus dacomitinib (Vizimpro) in EGFR-mutant non–small cell lung cancer.

x